Trial Library is a B2B health-technology platform that uses AI and evidence-based workflows to identify and pre-screen oncology patients, optimize internal referral routing, and provide pre-consent navigation to accelerate clinical trial enrollment.
Published Sep 19, 2026
No detailed public roadmap with dates was found in the reviewed sources.
No explicit performance benchmarks (e.g., patients screened per day, trials indexed, EHR response times) are publicly documented.
Trial Library’s Research Network materials include provider quotes indicating initial hesitation among some providers to offer trials because of perceived time burden and that the platform reduces operational friction. These are vendor-selected quotes and lack independent verification.
Materials from the Association of Community Cancer Centers reference Trial Library’s navigator service and describe it as improving visibility and navigation support for referring providers. These are partner or association descriptions and should be validated during diligence.
Glassdoor contains a small number of employee reviews. Some recent reviews were positive regarding mission and leadership but noted the typical fast-paced startup environment and staffing strain. An earlier review was mixed. Employee reviews reflect internal culture more than product performance.
A vendor blog post describes an intervention with lay patient navigators at a small number of cancer centers and reports increased participation versus predicted historical trends using a time-series analysis approach.
Critical evaluation:
A partner post describes the platform identifying multiple eligible patients for solid tumor trials during an early period after launch.
Critical evaluation:
Best fit appears to be multi-site oncology practices and networks (multi-site clinic networks) and health systems with hub-and-spoke referral complexity. Research programs with sufficient trial volume to make navigation and referral optimization ROI measurable are also plausible fits.
A practical working ICP range (estimate):
Decision makers:
End users:
Get a comprehensive analysis of Trial Library including market position, competitive landscape, adoption trends, and peer benchmarks.
Download full report →Trial Library does not appear to have meaningful coverage on major B2B SaaS review platforms (G2, TrustRadius, Gartner Peer Insights) in accessible search results. Attempts to locate product review pages did not surface credible listings.
As a result, this section relies more heavily on:
A vendor-published case study reports a large number of referrals in one year from engagement among community oncologists for pre-screening.
Critical evaluation:
Trial Library is a B2B health-technology platform focused on oncology clinical trial recruitment, pre-screening/patient identification, internal referral optimization, and pre-consent patient navigation. The company describes its platform as using artificial intelligence and an evidence-based approach to support patient identification, referral routing, and navigation throughout the trial enrollment process.
Key product modules described publicly include:
These modules are documented on public product pages and site materials, which highlight referral optimization, patient identification, and navigation services.
Trial Library primarily targets:
Positioning themes in public materials include a stated objective of increasing access to oncology clinical trials, and providing operational support for providers who lack time and infrastructure to match patients to trials. Materials also describe pre-consent navigation intended to address practical barriers (travel, lodging, etc.).